Who makes Direct boost mRNA?

Direct boost mRNA is developed by Erasmus Medical Center.

What development phase is Direct boost mRNA in?

Direct boost mRNA is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Direct boost mRNA

Erasmus Medical Center · Phase 1 active Small molecule

At a glance

Generic name	Direct boost mRNA
Sponsor	Erasmus Medical Center
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Direct boost mRNA CI brief — competitive landscape report
Direct boost mRNA updates RSS · CI watch RSS
Erasmus Medical Center portfolio CI